Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0026850 (
muscular dystrophy
)
5,870
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
AHNAK
is a 700-kDa protein involved in cytoarchitecture and calcium signaling. It is secondarily reduced in muscle of dysferlinopathy patients and accumulates in muscle of calpainopathy patients, both affected by a
muscular dystrophy
.
AHNAK
directly interacts with dysferlin. This interaction is lost on cleavage of
AHNAK
by the protease calpain 3, explaining the molecular observations in patients. Currently, little is known of
AHNAK
regulation. We describe the self-regulation of multiple mRNA transcripts emanating from the
AHNAK
locus in muscle cells. We show that the
AHNAK
gene consists of a 17-kb exon flanked by multiple small exons. This genetic structure is shared by AHNAK2 and Periaxin, which share a common ancestor. Two major
AHNAK
transcripts are differentially expressed during muscle differentiation that encode for a small (17-kDa) and a large (700-kDa) protein isoform. These proteins interact in the cytoplasm, but the small
AHNAK
is also present in the nucleus. During muscle differentiation the small
AHNAK
is strongly increased, thereby establishing a positive feedback loop to regulate mRNA splicing of its own locus. A small 17-kDa isoform of Periaxin similarly traffics between the cytoplasm and the nucleus to regulate mRNA splicing. Thus,
AHNAK
constitutes a novel mechanism in post-transcriptional control of gene expression.
...
PMID:Self-regulated alternative splicing at the AHNAK locus. 2194 Sep 93